An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD) - Trial 2015-001217-27
Access comprehensive clinical trial information for 2015-001217-27 through Pure Global AI's free database. This phase not specified trial is sponsored by Janssen Korea Ltd and is currently status unknown. The study focuses on Attention Deficit Hyperactivity Disorder.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Janssen Korea Ltd
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
- Participants who have known hypersensitivity (altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen) to methylphenidate HCL
ICD-10 Classifications
Data Source
EU Clinical Trials Register
2015-001217-27
Non-Device Trial